Structure

Physi-Chem Properties

Molecular Weight:  584.23
Volume:  568.994
LogP:  2.928
LogD:  2.465
LogS:  -4.059
# Rotatable Bonds:  7
TPSA:  154.89
# H-Bond Aceptor:  11
# H-Bond Donor:  2
# Rings:  6
# Heavy Atoms:  11

MedChem Properties

QED Drug-Likeness Score:  0.303
Synthetic Accessibility Score:  5.777
Fsp3:  0.613
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.463
MDCK Permeability:  8.76203557709232e-05
Pgp-inhibitor:  0.95
Pgp-substrate:  0.999
Human Intestinal Absorption (HIA):  0.323
20% Bioavailability (F20%):  0.989
30% Bioavailability (F30%):  0.997

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.59
Plasma Protein Binding (PPB):  58.255859375%
Volume Distribution (VD):  1.69
Pgp-substrate:  25.944101333618164%

ADMET: Metabolism

CYP1A2-inhibitor:  0.009
CYP1A2-substrate:  0.074
CYP2C19-inhibitor:  0.02
CYP2C19-substrate:  0.578
CYP2C9-inhibitor:  0.028
CYP2C9-substrate:  0.014
CYP2D6-inhibitor:  0.005
CYP2D6-substrate:  0.057
CYP3A4-inhibitor:  0.289
CYP3A4-substrate:  0.759

ADMET: Excretion

Clearance (CL):  4.627
Half-life (T1/2):  0.048

ADMET: Toxicity

hERG Blockers:  0.119
Human Hepatotoxicity (H-HT):  0.936
Drug-inuced Liver Injury (DILI):  0.954
AMES Toxicity:  0.788
Rat Oral Acute Toxicity:  0.869
Maximum Recommended Daily Dose:  0.93
Skin Sensitization:  0.494
Carcinogencity:  0.474
Eye Corrosion:  0.003
Eye Irritation:  0.011
Respiratory Toxicity:  0.986

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC473632

Natural Product ID:  NPC473632
Common Name*:   KIAGJENBRDLBMJ-BEZTUGLTSA-N
IUPAC Name:   n.a.
Synonyms:   13-O-Acetyl Wallifoliol
Standard InCHIKey:  KIAGJENBRDLBMJ-BEZTUGLTSA-N
Standard InCHI:  InChI=1S/C31H36O11/c1-15-19(39-16(2)32)13-29-22(15)31(37,26(36)42-27(29,4)5)28(6)20(34)12-21-30(14-38-21,41-17(3)33)23(28)24(29)40-25(35)18-10-8-7-9-11-18/h7-11,19-21,23-24,34,37H,12-14H2,1-6H3/t19-,20-,21+,23-,24-,28+,29-,30-,31+/m0/s1
SMILES:  CC(=O)O[C@H]1C[C@]23C(=C1C)[C@@](O)(C(=O)OC3(C)C)[C@]1([C@H]([C@@H]2OC(=O)c2ccccc2)[C@@]2(CO[C@@H]2C[C@@H]1O)OC(=O)C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL447667
PubChem CID:   21603521
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000264] Organic acids and derivatives
      • [CHEMONTID:0000265] Carboxylic acids and derivatives
        • [CHEMONTID:0002966] Tetracarboxylic acids and derivatives

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO11554 Taxus sumatrana Species Taxaceae Eukaryota n.a. leaf n.a. DOI[10.1016/j.tet.2004.10.110]
NPO11554 Taxus sumatrana Species Taxaceae Eukaryota n.a. twig n.a. DOI[10.1016/j.tet.2004.10.110]
NPO11554 Taxus sumatrana Species Taxaceae Eukaryota leaves and twigs n.a. n.a. PMID[12502326]
NPO11554 Taxus sumatrana Species Taxaceae Eukaryota n.a. twig n.a. PMID[15679325]
NPO11554 Taxus sumatrana Species Taxaceae Eukaryota n.a. leaf n.a. PMID[15679325]
NPO11554 Taxus sumatrana Species Taxaceae Eukaryota n.a. n.a. n.a. PMID[15679325]
NPO11554 Taxus sumatrana Species Taxaceae Eukaryota n.a. n.a. n.a. PMID[18220355]
NPO11554 Taxus sumatrana Species Taxaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO11554 Taxus sumatrana Species Taxaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO11554 Taxus sumatrana Species Taxaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT91 Cell Line KB Homo sapiens IC50 = 2.91 ug.mL-1 PMID[520383]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 13.92 ug.mL-1 PMID[520383]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC473632 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC469730
1.0 High Similarity NPC132599
0.9862 High Similarity NPC473611
0.9533 High Similarity NPC476077
0.9178 High Similarity NPC92867
0.9178 High Similarity NPC311825
0.9133 High Similarity NPC134685
0.9133 High Similarity NPC248265
0.9133 High Similarity NPC11588
0.9133 High Similarity NPC229545
0.9128 High Similarity NPC471103
0.9122 High Similarity NPC60509
0.9122 High Similarity NPC81698
0.9122 High Similarity NPC250046
0.9116 High Similarity NPC20255
0.9073 High Similarity NPC114357
0.9073 High Similarity NPC155329
0.9073 High Similarity NPC259144
0.9073 High Similarity NPC472549
0.906 High Similarity NPC198455
0.906 High Similarity NPC165260
0.906 High Similarity NPC7095
0.906 High Similarity NPC161239
0.9054 High Similarity NPC473760
0.9048 High Similarity NPC125882
0.9048 High Similarity NPC127857
0.9041 High Similarity NPC477894
0.9034 High Similarity NPC97947
0.9034 High Similarity NPC291599
0.9034 High Similarity NPC118080
0.9034 High Similarity NPC27377
0.9034 High Similarity NPC87448
0.9034 High Similarity NPC472576
0.9034 High Similarity NPC41481
0.9013 High Similarity NPC106895
0.9007 High Similarity NPC219419
0.9 High Similarity NPC197037
0.9 High Similarity NPC51602
0.9 High Similarity NPC470153
0.8993 High Similarity NPC476975
0.8986 High Similarity NPC209592
0.8986 High Similarity NPC48599
0.898 High Similarity NPC241951
0.898 High Similarity NPC34943
0.898 High Similarity NPC470152
0.898 High Similarity NPC38696
0.898 High Similarity NPC475759
0.8974 High Similarity NPC471134
0.8973 High Similarity NPC182869
0.8966 High Similarity NPC90614
0.8966 High Similarity NPC100913
0.8966 High Similarity NPC275592
0.8966 High Similarity NPC97667
0.8966 High Similarity NPC171207
0.8947 High Similarity NPC26033
0.8947 High Similarity NPC282239
0.8947 High Similarity NPC473670
0.8947 High Similarity NPC21410
0.8947 High Similarity NPC228204
0.894 High Similarity NPC472548
0.894 High Similarity NPC477905
0.8933 High Similarity NPC470245
0.8933 High Similarity NPC91730
0.8933 High Similarity NPC31829
0.8933 High Similarity NPC112216
0.8933 High Similarity NPC473214
0.8919 High Similarity NPC476973
0.8919 High Similarity NPC472571
0.8919 High Similarity NPC177940
0.8919 High Similarity NPC472572
0.8919 High Similarity NPC200471
0.8919 High Similarity NPC472575
0.8919 High Similarity NPC70403
0.8919 High Similarity NPC470159
0.8919 High Similarity NPC174982
0.8919 High Similarity NPC184817
0.8919 High Similarity NPC29704
0.8919 High Similarity NPC472556
0.8919 High Similarity NPC96903
0.8919 High Similarity NPC471104
0.8919 High Similarity NPC472568
0.8919 High Similarity NPC158663
0.8919 High Similarity NPC470157
0.8919 High Similarity NPC469349
0.8919 High Similarity NPC473088
0.8919 High Similarity NPC171525
0.8912 High Similarity NPC163087
0.8904 High Similarity NPC16912
0.8896 High Similarity NPC469399
0.8882 High Similarity NPC473414
0.8882 High Similarity NPC237549
0.8882 High Similarity NPC249471
0.8882 High Similarity NPC256142
0.8882 High Similarity NPC158333
0.8882 High Similarity NPC265395
0.8882 High Similarity NPC472005
0.8882 High Similarity NPC242262
0.8882 High Similarity NPC472030
0.8882 High Similarity NPC472022
0.8882 High Similarity NPC304876
0.8882 High Similarity NPC257213
0.8882 High Similarity NPC1173
0.8874 High Similarity NPC101043
0.8874 High Similarity NPC306799
0.8867 High Similarity NPC473215
0.8859 High Similarity NPC473602
0.8859 High Similarity NPC240115
0.8854 High Similarity NPC471493
0.8851 High Similarity NPC188865
0.8851 High Similarity NPC95265
0.8851 High Similarity NPC475122
0.8851 High Similarity NPC163719
0.8851 High Similarity NPC472570
0.8851 High Similarity NPC95810
0.8851 High Similarity NPC11685
0.8851 High Similarity NPC70716
0.8851 High Similarity NPC125106
0.8851 High Similarity NPC472573
0.8851 High Similarity NPC472569
0.8851 High Similarity NPC57628
0.8851 High Similarity NPC25768
0.8851 High Similarity NPC476974
0.8844 High Similarity NPC192658
0.8836 High Similarity NPC472547
0.8831 High Similarity NPC472393
0.8824 High Similarity NPC114410
0.8824 High Similarity NPC112523
0.8819 High Similarity NPC477893
0.8819 High Similarity NPC477896
0.8816 High Similarity NPC469647
0.8816 High Similarity NPC138641
0.8816 High Similarity NPC283875
0.8816 High Similarity NPC469648
0.8816 High Similarity NPC22571
0.88 High Similarity NPC217918
0.8792 High Similarity NPC471107
0.8792 High Similarity NPC471100
0.8784 High Similarity NPC91703
0.8784 High Similarity NPC95449
0.8774 High Similarity NPC471102
0.8767 High Similarity NPC9905
0.8766 High Similarity NPC217091
0.8766 High Similarity NPC11410
0.8758 High Similarity NPC133430
0.8758 High Similarity NPC469477
0.8758 High Similarity NPC77719
0.8742 High Similarity NPC471101
0.8742 High Similarity NPC270590
0.8742 High Similarity NPC266265
0.8742 High Similarity NPC92293
0.8742 High Similarity NPC301556
0.8742 High Similarity NPC161151
0.8733 High Similarity NPC474935
0.8733 High Similarity NPC478263
0.8716 High Similarity NPC472546
0.8716 High Similarity NPC34012
0.871 High Similarity NPC469771
0.871 High Similarity NPC469417
0.8707 High Similarity NPC87934
0.8707 High Similarity NPC162613
0.8701 High Similarity NPC34066
0.8701 High Similarity NPC251139
0.8699 High Similarity NPC39549
0.8693 High Similarity NPC233581
0.8693 High Similarity NPC145649
0.869 High Similarity NPC195647
0.869 High Similarity NPC66761
0.869 High Similarity NPC17877
0.869 High Similarity NPC291638
0.869 High Similarity NPC472577
0.8684 High Similarity NPC476173
0.8684 High Similarity NPC469448
0.8684 High Similarity NPC254558
0.8679 High Similarity NPC477491
0.8675 High Similarity NPC327031
0.8675 High Similarity NPC281717
0.8671 High Similarity NPC66193
0.8667 High Similarity NPC478264
0.8649 High Similarity NPC266374
0.8649 High Similarity NPC224491
0.8645 High Similarity NPC70344
0.863 High Similarity NPC472551
0.863 High Similarity NPC472545
0.8627 High Similarity NPC472398
0.8621 High Similarity NPC474608
0.8618 High Similarity NPC76103
0.8609 High Similarity NPC312393
0.86 High Similarity NPC470231
0.8581 High Similarity NPC184747
0.8581 High Similarity NPC476094
0.8581 High Similarity NPC5115
0.8581 High Similarity NPC4341
0.8581 High Similarity NPC473085
0.8581 High Similarity NPC477904
0.8581 High Similarity NPC48017
0.8581 High Similarity NPC473060
0.8581 High Similarity NPC200592
0.8581 High Similarity NPC147880
0.8581 High Similarity NPC43241
0.8581 High Similarity NPC473613

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC473632 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8421 Intermediate Similarity NPD7236 Approved
0.8269 Intermediate Similarity NPD7239 Suspended
0.8084 Intermediate Similarity NPD8470 Clinical (unspecified phase)
0.8047 Intermediate Similarity NPD8368 Discontinued
0.8035 Intermediate Similarity NPD8361 Approved
0.8035 Intermediate Similarity NPD8360 Approved
0.8024 Intermediate Similarity NPD7799 Discontinued
0.8023 Intermediate Similarity NPD8434 Phase 2
0.8012 Intermediate Similarity NPD8407 Phase 2
0.7931 Intermediate Similarity NPD8435 Approved
0.7816 Intermediate Similarity NPD8424 Clinical (unspecified phase)
0.7805 Intermediate Similarity NPD7058 Phase 2
0.7805 Intermediate Similarity NPD7057 Phase 3
0.7765 Intermediate Similarity NPD8485 Approved
0.7759 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7637 Intermediate Similarity NPD8486 Clinical (unspecified phase)
0.7614 Intermediate Similarity NPD8150 Discontinued
0.7547 Intermediate Similarity NPD6190 Approved
0.75 Intermediate Similarity NPD5952 Clinical (unspecified phase)
0.7468 Intermediate Similarity NPD7966 Clinical (unspecified phase)
0.7444 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7375 Intermediate Similarity NPD4628 Phase 3
0.7361 Intermediate Similarity NPD2629 Approved
0.7356 Intermediate Similarity NPD5844 Phase 1
0.7303 Intermediate Similarity NPD6007 Clinical (unspecified phase)
0.729 Intermediate Similarity NPD7961 Discontinued
0.7278 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7235 Intermediate Similarity NPD7075 Discontinued
0.7232 Intermediate Similarity NPD7685 Pre-registration
0.7209 Intermediate Similarity NPD8127 Discontinued
0.7192 Intermediate Similarity NPD4198 Discontinued
0.7162 Intermediate Similarity NPD7741 Discontinued
0.7161 Intermediate Similarity NPD7008 Discontinued
0.716 Intermediate Similarity NPD5761 Phase 2
0.716 Intermediate Similarity NPD5760 Phase 2
0.716 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7152 Intermediate Similarity NPD6273 Approved
0.7143 Intermediate Similarity NPD7497 Discontinued
0.7091 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7083 Intermediate Similarity NPD4380 Phase 2
0.7081 Intermediate Similarity NPD6535 Approved
0.7081 Intermediate Similarity NPD6534 Approved
0.7079 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7059 Intermediate Similarity NPD7700 Phase 2
0.7059 Intermediate Similarity NPD7699 Phase 2
0.7055 Intermediate Similarity NPD8166 Discontinued
0.7053 Intermediate Similarity NPD7435 Discontinued
0.7045 Intermediate Similarity NPD7473 Discontinued
0.7039 Intermediate Similarity NPD6764 Approved
0.7039 Intermediate Similarity NPD6765 Approved
0.7026 Intermediate Similarity NPD8462 Phase 1
0.7024 Intermediate Similarity NPD7458 Discontinued
0.7018 Intermediate Similarity NPD5402 Approved
0.7016 Intermediate Similarity NPD8320 Phase 1
0.7016 Intermediate Similarity NPD8319 Approved
0.7006 Intermediate Similarity NPD3764 Approved
0.7006 Intermediate Similarity NPD7228 Approved
0.7 Intermediate Similarity NPD37 Approved
0.7 Intermediate Similarity NPD6801 Discontinued
0.6989 Remote Similarity NPD6168 Clinical (unspecified phase)
0.6989 Remote Similarity NPD6167 Clinical (unspecified phase)
0.6989 Remote Similarity NPD6166 Phase 2
0.6982 Remote Similarity NPD6599 Discontinued
0.6977 Remote Similarity NPD4965 Approved
0.6977 Remote Similarity NPD4967 Phase 2
0.6977 Remote Similarity NPD4966 Approved
0.6971 Remote Similarity NPD6232 Discontinued
0.697 Remote Similarity NPD8404 Phase 2
0.6961 Remote Similarity NPD8312 Approved
0.6961 Remote Similarity NPD8313 Approved
0.6959 Remote Similarity NPD7819 Suspended
0.691 Remote Similarity NPD3751 Discontinued
0.6906 Remote Similarity NPD4338 Clinical (unspecified phase)
0.6897 Remote Similarity NPD5537 Clinical (unspecified phase)
0.6897 Remote Similarity NPD6234 Discontinued
0.6895 Remote Similarity NPD6779 Approved
0.6895 Remote Similarity NPD6781 Approved
0.6895 Remote Similarity NPD6780 Approved
0.6895 Remote Similarity NPD6778 Approved
0.6895 Remote Similarity NPD6782 Approved
0.6895 Remote Similarity NPD6777 Approved
0.6895 Remote Similarity NPD6776 Approved
0.6892 Remote Similarity NPD5951 Approved
0.6885 Remote Similarity NPD6784 Approved
0.6885 Remote Similarity NPD6785 Approved
0.6875 Remote Similarity NPD230 Phase 1
0.6872 Remote Similarity NPD7804 Clinical (unspecified phase)
0.6865 Remote Similarity NPD8397 Clinical (unspecified phase)
0.6857 Remote Similarity NPD5494 Approved
0.6855 Remote Similarity NPD6663 Approved
0.6849 Remote Similarity NPD2181 Clinical (unspecified phase)
0.6848 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6842 Remote Similarity NPD5125 Phase 3
0.6842 Remote Similarity NPD3412 Clinical (unspecified phase)
0.6842 Remote Similarity NPD5126 Approved
0.6842 Remote Similarity NPD7411 Suspended
0.6839 Remote Similarity NPD4381 Clinical (unspecified phase)
0.6837 Remote Similarity NPD7875 Clinical (unspecified phase)
0.6837 Remote Similarity NPD7874 Approved
0.6824 Remote Similarity NPD6591 Clinical (unspecified phase)
0.6824 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6821 Remote Similarity NPD3817 Phase 2
0.6821 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6815 Remote Similarity NPD5736 Approved
0.6807 Remote Similarity NPD7274 Clinical (unspecified phase)
0.6805 Remote Similarity NPD5403 Approved
0.6797 Remote Similarity NPD7457 Clinical (unspecified phase)
0.6788 Remote Similarity NPD7696 Phase 3
0.6788 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6788 Remote Similarity NPD7698 Approved
0.6788 Remote Similarity NPD7697 Approved
0.6786 Remote Similarity NPD2532 Approved
0.6786 Remote Similarity NPD2534 Approved
0.6786 Remote Similarity NPD2533 Approved
0.678 Remote Similarity NPD3787 Discontinued
0.6779 Remote Similarity NPD690 Clinical (unspecified phase)
0.6768 Remote Similarity NPD5762 Approved
0.6768 Remote Similarity NPD5763 Approved
0.6768 Remote Similarity NPD7702 Clinical (unspecified phase)
0.6768 Remote Similarity NPD7266 Discontinued
0.6763 Remote Similarity NPD1465 Phase 2
0.6763 Remote Similarity NPD2393 Clinical (unspecified phase)
0.6758 Remote Similarity NPD7240 Approved
0.6758 Remote Similarity NPD7251 Discontinued
0.6757 Remote Similarity NPD7094 Approved
0.6757 Remote Similarity NPD6858 Approved
0.6753 Remote Similarity NPD7871 Phase 2
0.6753 Remote Similarity NPD7870 Phase 2
0.6748 Remote Similarity NPD7305 Phase 1
0.6747 Remote Similarity NPD7003 Approved
0.6742 Remote Similarity NPD7184 Clinical (unspecified phase)
0.674 Remote Similarity NPD7074 Phase 3
0.6735 Remote Similarity NPD7701 Phase 2
0.6732 Remote Similarity NPD7163 Clinical (unspecified phase)
0.6726 Remote Similarity NPD6799 Approved
0.6725 Remote Similarity NPD3226 Approved
0.6723 Remote Similarity NPD7199 Phase 2
0.6722 Remote Similarity NPD3818 Discontinued
0.6721 Remote Similarity NPD7808 Phase 3
0.6717 Remote Similarity NPD7801 Approved
0.6712 Remote Similarity NPD2182 Approved
0.6712 Remote Similarity NPD6831 Clinical (unspecified phase)
0.6705 Remote Similarity NPD1934 Approved
0.6703 Remote Similarity NPD6797 Phase 2
0.6686 Remote Similarity NPD3882 Suspended
0.6686 Remote Similarity NPD8389 Clinical (unspecified phase)
0.6686 Remote Similarity NPD5401 Approved
0.6685 Remote Similarity NPD7054 Approved
0.6667 Remote Similarity NPD6355 Discontinued
0.6667 Remote Similarity NPD8455 Phase 2
0.6667 Remote Similarity NPD6559 Discontinued
0.6648 Remote Similarity NPD7472 Approved
0.6648 Remote Similarity NPD3749 Approved
0.6645 Remote Similarity NPD7610 Discontinued
0.6629 Remote Similarity NPD6959 Discontinued
0.6627 Remote Similarity NPD6143 Clinical (unspecified phase)
0.6611 Remote Similarity NPD7852 Clinical (unspecified phase)
0.6608 Remote Similarity NPD6980 Clinical (unspecified phase)
0.6606 Remote Similarity NPD6100 Approved
0.6606 Remote Similarity NPD6099 Approved
0.6603 Remote Similarity NPD7507 Approved
0.6601 Remote Similarity NPD9545 Approved
0.6591 Remote Similarity NPD7768 Phase 2
0.6588 Remote Similarity NPD7422 Clinical (unspecified phase)
0.6588 Remote Similarity NPD7410 Clinical (unspecified phase)
0.6588 Remote Similarity NPD4378 Clinical (unspecified phase)
0.6585 Remote Similarity NPD7097 Phase 1
0.6582 Remote Similarity NPD7319 Approved
0.6579 Remote Similarity NPD6214 Clinical (unspecified phase)
0.6579 Remote Similarity NPD6212 Phase 3
0.6579 Remote Similarity NPD6213 Phase 3
0.6571 Remote Similarity NPD2801 Approved
0.6566 Remote Similarity NPD6006 Clinical (unspecified phase)
0.6566 Remote Similarity NPD6004 Phase 3
0.6566 Remote Similarity NPD2346 Discontinued
0.6566 Remote Similarity NPD6002 Phase 3
0.6566 Remote Similarity NPD6005 Phase 3
0.6566 Remote Similarity NPD6003 Clinical (unspecified phase)
0.6564 Remote Similarity NPD6823 Phase 2
0.6554 Remote Similarity NPD2067 Discontinued
0.6548 Remote Similarity NPD7211 Clinical (unspecified phase)
0.6548 Remote Similarity NPD3750 Approved
0.6543 Remote Similarity NPD7714 Approved
0.6543 Remote Similarity NPD7715 Approved
0.6543 Remote Similarity NPD6233 Phase 2
0.6541 Remote Similarity NPD5740 Clinical (unspecified phase)
0.6541 Remote Similarity NPD6085 Phase 2
0.6538 Remote Similarity NPD4807 Approved
0.6538 Remote Similarity NPD4806 Approved
0.6533 Remote Similarity NPD8151 Discontinued
0.6531 Remote Similarity NPD5345 Clinical (unspecified phase)
0.6527 Remote Similarity NPD970 Clinical (unspecified phase)
0.6522 Remote Similarity NPD7095 Approved
0.6516 Remote Similarity NPD5306 Approved
0.6516 Remote Similarity NPD5305 Approved
0.651 Remote Similarity NPD4141 Clinical (unspecified phase)
0.6506 Remote Similarity NPD5406 Approved
0.6506 Remote Similarity NPD5404 Approved
0.6506 Remote Similarity NPD2935 Discontinued
0.6506 Remote Similarity NPD5408 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data